IP Verse

Safety Device For A Pre-Filled Syringe And Injection Device - EP2588167B1

PatentPatent Analysis

EP2588167

SANOFI AVENTIS DEUTSCHLAND
Application Number
EP11726438A
Filing Date
Jun 21, 2011
Status
Opposition Rejected
Mar 4, 2022
Grant Date
Feb 21, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4056212B1
EP2788050B2
EP3307357B2

Bibliography

The patent EP2588167B1 was granted to Sanofi Aventis Deutschland on Feb 21, 2018 following the initial filing on Jun 21, 2011 under the application number EP11726438A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

WEST PHARMACEUTICAL SERVICESNov 21, 2018ADMISSIBLE
JANSSEN PHARMACEUTICALSNov 21, 2018WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents